Good Papers

BrainTAP: Brain Disorder Prediction with Adaptive Distill and Selective Prior Integration

BrainTAP predicts brain disorders by adaptively distilling cross-modal connectivity features and selectively fusing expert anatomical priors to outperform baselines on the ABCD dataset.

Zhenyu Lei, Aiying Zhang, Song Wang, Han Fan, Jundong Li

Published Jan 15, 2026

74%
OverallHighly rated
?
OverallHighly ratedVote to see the scoreThe exact score shows once you've voted, so every vote is your own call. The first half of each home page shelf shows its scores.
Readers
–

Only vote on papers you've read. Sign in with GitHub to vote.

AI panel9/20reviewers recommend it
lenient 5/5
medium 3/10
strict 1/5
AI panel?Vote to see what the 20 AI reviewers said
Panel consensus
BrainTAP earns praise for genuinely treating functional and structural connectivity differently through adaptive mutual distillation and selective prior fusion.

Abstract

Predicting clinical outcomes from brain networks in large-scale neuroimaging cohorts such as the Adolescent Brain Cognitive Development (ABCD) study requires effectively integrating functional connectivity (FC) and structural connectivity (SC) while incorporating expert neurobiological knowledge. However, existing multimodal fusion approaches are shallow or over-homogenize the inherently heterogeneous characteristics of FC and SC, while expert-defined anatomical priors are underutilized with static integration. To address these limitations, we propose Brain Transformer with Adaptive Mutual-Distill and Selective Prior Fusion (BrainTAP). We introduce Adaptive Mutual Distill (AMD), which enables layer-wise information exchange between modalities through learnable distill-intact ratios, preserving modality-specific signals while capturing cross-modal synergies. We further develop Selective Prior Fusion (SPF), which integrates expert-defined anatomical priors in an adaptive way. Evaluated on the ABCD dataset for predicting attention-related disorders, BrainTAP achieves superior performance over state-of-the-art baselines, demonstrating its effectiveness for brain disorder prediction.